The Disease Severity In Patients With Psoriasis
NCT05943405 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 33
Last updated 2023-07-13
Summary
This observational study aims to evaluate new markers to predict disease activity in psoriasis. The main question is SGOT, SGPT, GGT, hs-CRP, and apo B related to disease severity in psoriasis.
Conditions
Sponsors & Collaborators
-
Universitas Sebelas Maret
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-01
- Primary Completion
- 2022-12-30
- Completion
- 2022-12-30
Countries
- Indonesia
Study Locations
More Related Trials
-
Premature Coronary Artery Disease (CAD) in Severe Psoriasis
NCT00893126 ·Status: COMPLETED
-
Interleukin 38 as a Biomarker for Metabolic Syndrome in Psoriatic Patients
NCT05076812 ·Status: UNKNOWN
-
Cross-sectional Evaluation of Biological Markers of Cardiovascular Disease in Children and Adolescents With Psoriasis
NCT01122095 ·Status: UNKNOWN
-
Personal Precise Treatment on Psoriasis and Psoriatic Arthritis
NCT04915105 ·Status: UNKNOWN ·Phase: NA
-
Ultrasound Study of Entheses and Small Joints of Hands and Feet in Patients With Atypical Form of Psoriasis
NCT02899429 ·Status: COMPLETED
-
Association Between the Occurrence of a Clinical RElapse and Gut MIcrobiota Modifications: a Cohort Study of Patients With pSOriasis
NCT06055699 ·Status: NOT_YET_RECRUITING
-
A Study to Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in China
NCT03236870 ·Status: COMPLETED
-
Cytokine Expression in Psoriasis Patients with and Without Joint Involvement
NCT05307809 ·Status: RECRUITING ·Phase: NA
-
Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study
NCT01522742 ·Status: TERMINATED
-
COVID-19 Associated With Psoriasis
NCT05961605 ·Status: UNKNOWN
-
Long-Term Follow-Up Study of Psoriasis Patients
NCT00131066 ·Status: COMPLETED
-
Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With Apremilast
NCT03442088 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess Treatment Patterns, Clinical Outcomes and Healthcare Resource Utilization Among Adult Participants With Moderate-To-Severe Plaque Psoriasis
NCT05547490 ·Status: COMPLETED
-
Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation
NCT02330380 ·Status: COMPLETED
-
Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)
NCT02346240 ·Status: COMPLETED ·Phase: PHASE3
-
Sonographic Analysis of Nails in Psoriatic Arthritis and Healthy Controls
NCT04718428 ·Status: COMPLETED
-
The CorEvitas Psoriasis (PSO) Registry
NCT02707341 ·Status: ENROLLING_BY_INVITATION
-
Real-World Outcome of Psoriasis Subjects in Korea on Adalimumab
NCT03099083 ·Status: COMPLETED
-
A Study to Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO)
NCT06122649 ·Status: COMPLETED ·Phase: PHASE3
-
Immunoclassification of Psoriasis: a Strategy for Precision Medicine
NCT05503875 ·Status: RECRUITING ·Phase: NA
-
Etanercept Plus UVB-311nm Phototherapy in Psoriasis
NCT00550030 ·Status: COMPLETED ·Phase: NA
-
The Immunological Basis for Treatment Resistance to Anti-TNF Treatments
NCT01971346 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess the Reliability of PASI Scoring Using Digital-Based Images
NCT05835843 ·Status: COMPLETED
-
A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting
NCT05701995 ·Status: COMPLETED ·Phase: PHASE4
-
The Impact of Targeted Therapy on Microorganism in Patients With Psoriasis
NCT01504113 ·Status: UNKNOWN